ATE377417T1 - Verwendung von stickstoffoxyddonoren oder - antagonisten zur regulierung der dehnung der zervix - Google Patents

Verwendung von stickstoffoxyddonoren oder - antagonisten zur regulierung der dehnung der zervix

Info

Publication number
ATE377417T1
ATE377417T1 AT96909707T AT96909707T ATE377417T1 AT E377417 T1 ATE377417 T1 AT E377417T1 AT 96909707 T AT96909707 T AT 96909707T AT 96909707 T AT96909707 T AT 96909707T AT E377417 T1 ATE377417 T1 AT E377417T1
Authority
AT
Austria
Prior art keywords
donors
nitric oxide
oxyd
distention
cervix
Prior art date
Application number
AT96909707T
Other languages
English (en)
Inventor
Kristof Chwalisz
Robert E Garfield
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Application granted granted Critical
Publication of ATE377417T1 publication Critical patent/ATE377417T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
AT96909707T 1995-03-14 1996-03-14 Verwendung von stickstoffoxyddonoren oder - antagonisten zur regulierung der dehnung der zervix ATE377417T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95250059 1995-03-14

Publications (1)

Publication Number Publication Date
ATE377417T1 true ATE377417T1 (de) 2007-11-15

Family

ID=8221039

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96909707T ATE377417T1 (de) 1995-03-14 1996-03-14 Verwendung von stickstoffoxyddonoren oder - antagonisten zur regulierung der dehnung der zervix

Country Status (26)

Country Link
US (1) US6333350B1 (de)
EP (1) EP0814785B1 (de)
JP (1) JP4579349B2 (de)
KR (2) KR100434239B1 (de)
CN (1) CN1151781C (de)
AT (1) ATE377417T1 (de)
AU (1) AU713172B2 (de)
CA (1) CA2214779A1 (de)
CZ (1) CZ292395B6 (de)
DE (1) DE69637313T2 (de)
ES (1) ES2297838T3 (de)
HU (1) HUP9800826A3 (de)
ID (1) ID20742A (de)
IL (1) IL117496A (de)
IS (1) IS4555A (de)
MX (1) MX9707007A (de)
MY (1) MY116500A (de)
NO (1) NO318598B1 (de)
NZ (1) NZ305169A (de)
PL (1) PL183461B1 (de)
RU (1) RU2199346C2 (de)
SK (1) SK124197A3 (de)
TW (1) TW421594B (de)
UA (1) UA57703C2 (de)
WO (1) WO1996028145A1 (de)
ZA (1) ZA962089B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1151781C (zh) 1995-03-14 2004-06-02 舍林股份公司 一氧化氮的供体或者一氧化氮的抑制剂调节子宫颈扩张和伸展的用途
WO1997031631A1 (en) * 1996-02-27 1997-09-04 Rpms Technology Limited Cox-2 selective inhibitors for managing labour and uterine contractions
US6232434B1 (en) 1996-08-02 2001-05-15 Duke University Medical Center Polymers for delivering nitric oxide in vivo
DE19809845A1 (de) * 1998-03-03 1999-09-09 Jenapharm Gmbh S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
ITMI20002117A1 (it) * 2000-09-29 2002-03-29 Ibsa Inst Biochimique Sa Uso di sodio nitroprussiato in ostetricia e ginecologia
US20050113409A1 (en) * 2003-09-03 2005-05-26 Pharmacia Corporation Method for the prevention or treatment of pain, inflammation and inflammation-related disorders with a Cox-2 selective inhibitor in combination with a nitric oxide-donating agent and compositions therewith
RU2267133C2 (ru) * 2004-03-04 2005-12-27 Государственное учреждение "Ивановский научно-исследовательский институт материнства и детства им. В.Н. Городкова" Минздрава России Способ диагностики угрозы преждевременных родов
WO2006089561A1 (en) * 2005-02-23 2006-08-31 Abbas Abdelsalam Ghazi Pharmaceutical compositions containing organic acids useful for softening and ripening uterine cervix.
US8828981B2 (en) 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
CN102283827A (zh) * 2008-10-16 2011-12-21 四川维信医药科技有限责任公司 单硝酸异山梨酯的新用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993007114A1 (en) * 1991-09-24 1993-04-15 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs
US5508045A (en) 1992-10-09 1996-04-16 The Regents Of The University Of California Method and agents for control and management of labor during pregnancy
US5895783A (en) * 1993-07-16 1999-04-20 Schering Aktiengesellschaft Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor
FI962109A7 (fi) * 1993-11-16 1996-07-15 Schering Ag Kohdun supistumishäiriöiden hoito typpioksidisyntaasin substraatilla j a/tai luovuttajalla tai typpioksidi-inhibiittorilla
US5550369A (en) 1994-02-28 1996-08-27 Electro-Pro, Inc. Triangulation position detection method and apparatus
CN1151781C (zh) 1995-03-14 2004-06-02 舍林股份公司 一氧化氮的供体或者一氧化氮的抑制剂调节子宫颈扩张和伸展的用途

Also Published As

Publication number Publication date
NZ305169A (en) 1999-10-28
IS4555A (is) 1997-09-05
CZ292395B6 (cs) 2003-09-17
CA2214779A1 (en) 1996-09-19
KR100434239B1 (ko) 2004-06-09
JP4579349B2 (ja) 2010-11-10
KR100434238B1 (ko) 2004-07-16
NO974204D0 (no) 1997-09-12
EP0814785B1 (de) 2007-11-07
IL117496A (en) 2002-12-01
AU713172B2 (en) 1999-11-25
ES2297838T3 (es) 2008-05-01
JPH11502200A (ja) 1999-02-23
AU5311796A (en) 1996-10-02
CZ285197A3 (cs) 1998-03-18
RU2199346C2 (ru) 2003-02-27
UA57703C2 (uk) 2003-07-15
HUP9800826A3 (en) 1998-08-28
PL183461B1 (pl) 2002-06-28
NO318598B1 (no) 2005-04-18
SK124197A3 (en) 1998-06-03
WO1996028145A1 (en) 1996-09-19
KR20040004515A (ko) 2004-01-13
US6333350B1 (en) 2001-12-25
EP0814785A1 (de) 1998-01-07
ZA962089B (en) 1997-08-27
PL322252A1 (en) 1998-01-19
DE69637313T2 (de) 2008-09-04
KR19980703060A (ko) 1998-09-05
HUP9800826A1 (hu) 1998-07-28
IL117496A0 (en) 1997-03-18
MY116500A (en) 2004-02-28
TW421594B (en) 2001-02-11
DE69637313D1 (de) 2007-12-20
MX9707007A (es) 1998-06-30
CN1182366A (zh) 1998-05-20
CN1151781C (zh) 2004-06-02
ID20742A (id) 1999-02-25
NO974204L (no) 1997-11-13

Similar Documents

Publication Publication Date Title
ATE377417T1 (de) Verwendung von stickstoffoxyddonoren oder - antagonisten zur regulierung der dehnung der zervix
NO932388D0 (no) Fremgangsmaate til fraktur-syrebehandling av undervannsformasjoner
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
ATE297383T1 (de) Hemmung der p38 kinase unter verwendung von symmetrischen und asymmetrischen diphenylharnstoffen
ZA963281B (en) Alpha-substituted pyrimidine-thioalkyl and alkylether compounds.
DK0728006T3 (da) Anvendelse af mannosephosphater til behandlingen af fibrotiske lidelser
NO952469D0 (no) Terapautisk kombinasjon som inneholder interferon
NO307027B1 (no) Anvendelse av riluzol ved behandling av neurologiske lesjoner relatert til traumatiske skader
DK0634175T3 (da) Farmaceutisk kombination, der indeholder en hæmmer af renin-angiotensin-systemet og en endothelin-antagonist
ATE229331T1 (de) Inhibitoren von metazoan-parasit-proteasen
DE69814444D1 (de) Kombination von angiotensing-convertin-enzyme hemmern mit diuretikum zur behandlung von störungen der mikrozirkulation
ITMI922263A1 (it) Ammine eterocicliche utili nella terapia dell'asma e dell'infiammazione delle vie aeree
NO960775L (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
NO983906D0 (no) Anvendelse av karboniske anhydraseinhibitorer for behandling av makulær ödem
NO984950L (no) Forbindelser med veksthormonfrigj°rende egenskaper
ATE212833T1 (de) Verwendung von stickstoffoxid-synthase-substrat und/oder -donor oder stickstoffoxidhemmer zur herstellung von medikamenten zur behandlung von störungen der uterinen kontraktilität
GR3036241T3 (en) METHOD OF TREATMENT OF CHRONIC PROSTATITIS WITH 17-g(b)-N-MONOSUBSTITUTED-CARBAMOYL-4-AZA-5-g(a)-ANDROST-1-EN-3-ONES.
FI952018A0 (fi) BHAP-yhdisteiden käyttö yhdessä muiden ei-nukleosidi-käänteistransskriptaasi-inhibiittoreiden kanssa HIV-infektion hoitoon
ATE184199T1 (de) Verwendung von lokal appliziertem faktor xiii zur verhinderung von blutungen
FI950696A0 (fi) Menetelmä HIV:n replikaation estämiseksi IL-4:ää käyttämällä
ATE233570T1 (de) Verwendung des leukämie-inhibitor-faktor und endothelin antagonisten
DE59410340D1 (de) Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen
DE68919301D1 (de) Verwendung eines Prolylendopeptidase-Inhibitors zur Behandlung von AIDS.
MX9603898A (es) Bioensayo para inhibidores de transcriptasa inversa.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties